These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8995444)
1. Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line. Davidson D; Chow LM; Veillette A J Biol Chem; 1997 Jan; 272(2):1355-62. PubMed ID: 8995444 [TBL] [Abstract][Full Text] [Related]
2. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649 [TBL] [Abstract][Full Text] [Related]
3. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells. Grgurevich S; Mikhael A; McVicar DW Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957 [TBL] [Abstract][Full Text] [Related]
4. Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes. Cloutier JF; Chow LM; Veillette A Mol Cell Biol; 1995 Nov; 15(11):5937-44. PubMed ID: 7565746 [TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase. Ayrapetov MK; Lee S; Sun G Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803 [TBL] [Abstract][Full Text] [Related]
6. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets. Hirao A; Hamaguchi I; Suda T; Yamaguchi N EMBO J; 1997 May; 16(9):2342-51. PubMed ID: 9171348 [TBL] [Abstract][Full Text] [Related]
7. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases. Chong YP; Mulhern TD; Cheng HC Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715 [TBL] [Abstract][Full Text] [Related]
8. Functional analysis of Csk and CHK kinases in breast cancer cells. Bougeret C; Jiang S; Keydar I; Avraham H J Biol Chem; 2001 Sep; 276(36):33711-20. PubMed ID: 11445575 [TBL] [Abstract][Full Text] [Related]
9. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine. Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162 [TBL] [Abstract][Full Text] [Related]
10. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation. Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599 [TBL] [Abstract][Full Text] [Related]
11. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice. Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283 [TBL] [Abstract][Full Text] [Related]
12. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner. Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623 [TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes. McVicar DW; Lal BK; Lloyd A; Kawamura M; Chen YQ; Zhang X; Staples JE; Ortaldo JR; O'Shea JJ Oncogene; 1994 Jul; 9(7):2037-44. PubMed ID: 7516063 [TBL] [Abstract][Full Text] [Related]
14. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. Okada M; Nada S; Yamanashi Y; Yamamoto T; Nakagawa H J Biol Chem; 1991 Dec; 266(36):24249-52. PubMed ID: 1722201 [TBL] [Abstract][Full Text] [Related]
15. Analysis of CSK homologous kinase (CHK/HYL) in hematopoiesis by utilizing gene knockout mice. Hamaguchi I; Yamaguchi N; Suda J; Iwama A; Hirao A; Hashiyama M; Aizawa S; Suda T Biochem Biophys Res Commun; 1996 Jul; 224(1):172-9. PubMed ID: 8694808 [TBL] [Abstract][Full Text] [Related]
16. Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells. Zrihan-Licht S; Lim J; Keydar I; Sliwkowski MX; Groopman JE; Avraham H J Biol Chem; 1997 Jan; 272(3):1856-63. PubMed ID: 8999872 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors. Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911 [TBL] [Abstract][Full Text] [Related]
18. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK. Mikkola ET; Bergman M FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading. Hirao A; Huang XL; Suda T; Yamaguchi N J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]